{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:55Z","timestamp":1792783435505,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Jiangxi Provincial Natural Science Foundation General Project","award":["20232BAB206032"],"award-info":[{"award-number":["20232BAB206032"]}]},{"name":"Clinical Research Project of the Second Affiliated Hospital of Nanchang University","award":["2021 EFYB02"],"award-info":[{"award-number":["2021 EFYB02"]}],"id":[{"id":"https:\/\/ror.org\/01nxv5c88","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Science and Technology Program of Jiangxi Administration of Traditional Chinese Medicine","award":["2021A029"],"award-info":[{"award-number":["2021A029"]}],"id":[{"id":"https:\/\/ror.org\/027hagy81","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12325-026-03712-2","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T10:05:43Z","timestamp":1784801143000},"page":"4812-4847","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Regional Citrate Anticoagulation Versus No Anticoagulation During Continuous Renal Replacement Therapy in Critically Ill Patients at High Risk of Bleeding: A Meta-analysis of Randomized Controlled Trials"],"prefix":"10.1007","volume":"43","author":[{"given":"Wenlong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2863-0161","authenticated-orcid":false,"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"1","key":"3712_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-025-05817-6","volume":"30","author":"M Meersch-Dini","year":"2026","unstructured":"Meersch-Dini M, Abu-Tair M, Bayer M, Brinkmann A, Bellmann R, Brunkhorst F, et al. Multidisciplinary guidelines on renal replacement therapy in intensive care medicine. Crit Care. 2026;30(1):46. https:\/\/doi.org\/10.1186\/s13054-025-05817-6.","journal-title":"Crit Care"},{"key":"3712_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ph17121571","author":"L Erd\u00e9lyi","year":"2024","unstructured":"Erd\u00e9lyi L, Tr\u00e1sy D. CRRT is more than just continuous renal replacement therapy. Pharmaceuticals (Basel). 2024. https:\/\/doi.org\/10.3390\/ph17121571.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"44","key":"3712_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000045094","volume":"104","author":"P Li","year":"2025","unstructured":"Li P, Wu Z, Zhao M, Chen F. Comparative evaluation of continuous renal replacement therapy and intermittent hemodialysis for the treatment of acute kidney injury. Medicine (Baltimore). 2025;104(44):e45094. https:\/\/doi.org\/10.1097\/md.0000000000045094.","journal-title":"Medicine (Baltimore)"},{"key":"3712_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/8688974","volume":"2023","author":"H Ma","year":"2023","unstructured":"Ma H, Liu H, Liu Y, Wang Y, He J, Yang Q. Efficacy of continuous renal replacement therapy and intermittent hemodialysis in patients with renal failure in intensive care unit: a systemic review and meta-analysis. Evid Based Complement Alternat Med. 2023;2023:8688974. https:\/\/doi.org\/10.1155\/2023\/8688974.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"5","key":"3712_CR5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.xkme.2021.05.006","volume":"3","author":"S Verma","year":"2021","unstructured":"Verma S, Palevsky PM. Prescribing continuous kidney replacement therapy in acute kidney injury: a narrative review. Kidney Med. 2021;3(5):827\u201336. https:\/\/doi.org\/10.1016\/j.xkme.2021.05.006.","journal-title":"Kidney Med"},{"issue":"4","key":"3712_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/cc5937","volume":"11","author":"M Joannidis","year":"2007","unstructured":"Joannidis M, Oudemans-van Straaten HM. Clinical review: patency of the circuit in continuous renal replacement therapy. Crit Care. 2007;11(4):218. https:\/\/doi.org\/10.1186\/cc5937.","journal-title":"Crit Care"},{"issue":"1","key":"3712_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04519-1","volume":"27","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Liu C, Yang Y, Wang F, Zhang L, Fu P. Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials. Crit Care. 2023;27(1):222. https:\/\/doi.org\/10.1186\/s13054-023-04519-1.","journal-title":"Crit Care"},{"issue":"3","key":"3712_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/sdi.12946","volume":"34","author":"W Zhang","year":"2021","unstructured":"Zhang W, Bai M, Yu Y, Chen X, Zhao L. Continuous renal replacement therapy without anticoagulation in critically ill patients at high risk of bleeding: a systematic review and meta-analysis. Semin Dial. 2021;34(3):196\u2013208. https:\/\/doi.org\/10.1111\/sdi.12946.","journal-title":"Semin Dial"},{"issue":"1","key":"3712_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s44158-023-00091-w","volume":"3","author":"V Pistolesi","year":"2023","unstructured":"Pistolesi V, Morabito S, Pota V, Valente F, Di Mario F, Fiaccadori E, et al. Regional citrate anticoagulation (RCA) in critically ill patients undergoing renal replacement therapy (RRT): expert opinion from the SIAARTI-SIN joint commission. J Anesth Analg Crit Care. 2023;3(1):7. https:\/\/doi.org\/10.1186\/s44158-023-00091-w.","journal-title":"J Anesth Analg Crit Care"},{"issue":"1","key":"3712_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-023-00457-9","volume":"10","author":"SY Liu","year":"2023","unstructured":"Liu SY, Xu SY, Yin L, Yang T, Jin K, Zhang QB, et al. Management of regional citrate anticoagulation for continuous renal replacement therapy: guideline recommendations from Chinese emergency medical doctor consensus. Mil Med Res. 2023;10(1):23. https:\/\/doi.org\/10.1186\/s40779-023-00457-9.","journal-title":"Mil Med Res"},{"issue":"2","key":"3712_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/hdi.13003","volume":"26","author":"R Raina","year":"2022","unstructured":"Raina R, Sethi S, Khooblall A, Kher V, Deshpande S, Yerigeri K, et al. Non-anticoagulation pediatric continuous renal replacement therapy methods to increase circuit life. Hemodial Int. 2022;26(2):147\u201359. https:\/\/doi.org\/10.1111\/hdi.13003.","journal-title":"Hemodial Int"},{"issue":"1","key":"3712_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12912-025-03762-x","volume":"24","author":"F Wang","year":"2025","unstructured":"Wang F, Lin L, Li P, Huang X, Ye T, Sun X, et al. Saline flushing to prevent circuit clotting during CRRT without anticoagulant: a randomized controlled study. BMC Nurs. 2025;24(1):1109. https:\/\/doi.org\/10.1186\/s12912-025-03762-x.","journal-title":"BMC Nurs"},{"issue":"6","key":"3712_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3760\/cma.j.issn.1001-7097.2014.06.001","volume":"30","author":"ST Yang","year":"2014","unstructured":"Yang ST, Zhao N, Li B, Wang XQ, Xiao YF. ACD-A solution as anticoagulant during continuous renal replacement therapy in high-risk bleeding patients. Chin J Nephrol. 2014;30(6):401\u20135. https:\/\/doi.org\/10.3760\/cma.j.issn.1001-7097.2014.06.001.","journal-title":"Chin J Nephrol"},{"issue":"3","key":"3712_CR14","first-page":"295","volume":"19","author":"S Li","year":"2016","unstructured":"Li S, Hao MW, Zhang J, Zhong MM, Zhang L. Comparison of different anticoagulation strategies during continuous veno-venous hemofiltration in patients with multiple organ dysfunction syndrome. Chin J Clin Healthcare. 2016;19(3):295\u20137.","journal-title":"Chin J Clin Healthcare"},{"issue":"7","key":"3712_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3969\/j.issn.1005-1678.2016.07.027","volume":"36","author":"QY Wang","year":"2016","unstructured":"Wang QY, Yang FF, Xu SY, Cai JM. Application of local citrate anticoagulation in continuous renal repIacement therapy patients with high risk of bleeding. Chin J Biochem Pharm. 2016;36(7):91\u20133. https:\/\/doi.org\/10.3969\/j.issn.1005-1678.2016.07.027.","journal-title":"Chin J Biochem Pharm"},{"issue":"8","key":"3712_CR16","first-page":"939","volume":"21","author":"YF Yu","year":"2016","unstructured":"Yu YF, Zhang LQ, Yu ZH. Regional citrate anticoagulation effect of proinflammatory cytokines in patients with high risk of hemorrhage of acute kidney injury. Chin J Clin Pharmacol Ther. 2016;21(8):939\u201342.","journal-title":"Chin J Clin Pharmacol Ther"},{"issue":"4","key":"3712_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3969\/j.issn.1009-0959.2016.04.024","volume":"18","author":"GZ Zhong","year":"2016","unstructured":"Zhong GZ, Hu PF. Analysis of the efficacy of CRRT in treating different anticoagulation in sepsis. Chin J Med Guide. 2016;18(4):371\u20132. https:\/\/doi.org\/10.3969\/j.issn.1009-0959.2016.04.024.","journal-title":"Chin J Med Guide"},{"key":"3712_CR18","doi-asserted-by":"publisher","unstructured":"Gao JP, Wang F, Wang YG, L. L, Pan KH. A pilot study of regional citrate anticoagulation for continuous renal replacement therapy in patients with acute kidney injury at high risk of bleeding. Chin J Emerg Med. 2017. https:\/\/doi.org\/10.3760\/cma.j.issn.1671-0282.2017.09.009.","DOI":"10.3760\/cma.j.issn.1671-0282.2017.09.009"},{"issue":"1","key":"3712_CR19","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20176378","volume":"51","author":"B Tuerdi","year":"2017","unstructured":"Tuerdi B, Zuo L, Sun H, Wang K, Wang Z, Li G. Safety and efficacy of regional citrate anticoagulation in continuous blood purification treatment of patients with multiple organ dysfunction syndrome. Braz J Med Biol Res. 2017;51(1):e6378. https:\/\/doi.org\/10.1590\/1414-431x20176378.","journal-title":"Braz J Med Biol Res"},{"issue":"21","key":"3712_CR20","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3760\/cma.j.issn.1672-7088.2017.21.003","volume":"33","author":"ZH Xu","year":"2017","unstructured":"Xu ZH, Pan H, Huang QH, Cao Y, Zhou J, Wang HX, et al. Application of citrate anticoagulation with continuous renal replacement therapy at high risk of bleeding patients. Chin J Prac Nurs. 2017;33(21):1609\u201311. https:\/\/doi.org\/10.3760\/cma.j.issn.1672-7088.2017.21.003.","journal-title":"Chin J Prac Nurs"},{"issue":"10","key":"3712_CR21","doi-asserted-by":"publisher","first-page":"725","DOI":"10.16047\/j.cnki.cn14-1300\/r.2017.10.002","volume":"26","author":"SR Zhang","year":"2017","unstructured":"Zhang SR, Zhu YL, Kuang ZM, Zhu HY, Huang ZF. Comparative analysis of citrate anticoagulation and non - anticoagulant hemofiltration in the treatment of renal failure with cerebral hemorrhage. Proc Clin Med. 2017;26(10):725\u20137. https:\/\/doi.org\/10.16047\/j.cnki.cn14-1300\/r.2017.10.002.","journal-title":"Proc Clin Med"},{"issue":"33","key":"3712_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3969\/j.issn.1009-4393.2018.33.036","volume":"24","author":"HJ Zhou","year":"2018","unstructured":"Zhou HJ, Liu GL, Liu SB. Application of citrate anticoagulation in blood purification therapy for patients with early acute kidney injury after cardiac surgery. Contemp Med. 2018;24(33):84\u20136. https:\/\/doi.org\/10.3969\/j.issn.1009-4393.2018.33.036.","journal-title":"Contemp Med"},{"issue":"1","key":"3712_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42916-1","volume":"9","author":"J Gao","year":"2019","unstructured":"Gao J, Wang F, Wang Y, Jin D, Tang L, Pan K. A mode of CVVH with regional citrate anticoagulation compared to no anticoagulation for acute kidney injury patients at high risk of bleeding. Sci Rep. 2019;9(1):6607. https:\/\/doi.org\/10.1038\/s41598-019-42916-1.","journal-title":"Sci Rep"},{"issue":"10","key":"3712_CR24","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.14053\/j.cnki.ppcr.201910010","volume":"22","author":"QL Liu","year":"2019","unstructured":"Liu QL, Wang YL, Wang ZF. Clinical evaluation of sodium citrate anticoagulation for blood purification in patients with moderate- and high-risk hemorrhage. Pract Pharm Clin Remedies. 2019;22(10):1051\u20134. https:\/\/doi.org\/10.14053\/j.cnki.ppcr.201910010.","journal-title":"Pract Pharm Clin Remedies"},{"key":"3712_CR25","doi-asserted-by":"publisher","DOI":"10.1177\/10760296211050640","volume":"27","author":"K Xun","year":"2021","unstructured":"Xun K, Qiu H, Jia M, Lin L, He M, Li D, et al. Treatment effect of regional sodium citrate anticoagulation in elderly patients with high-risk bleeding receiving continuous renal replacement therapy. Clin Appl Thromb Hemost. 2021;27:10760296211050640. https:\/\/doi.org\/10.1177\/10760296211050640.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"11","key":"3712_CR26","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.11675\/j.issn.0253-4304.2021.11.02","volume":"43","author":"YH Yi","year":"2021","unstructured":"Yi YH, Tan XS, Yi H, Bin WX, Xu Y. Application efficacy of continuous renal replacement therapy with different anticoagulation methods in patients with traumatic coagulopathy complicated with acute respiratory distress syndrome: a comparative study. Guangxi Med J. 2021;43(11):1285\u201390. https:\/\/doi.org\/10.11675\/j.issn.0253-4304.2021.11.02.","journal-title":"Guangxi Med J"},{"issue":"5","key":"3712_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1159\/000529076","volume":"52","author":"R Ratanarat","year":"2023","unstructured":"Ratanarat R, Phairatwet P, Khansompop S, Naorungroj T. Customized citrate anticoagulation versus no anticoagulant in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a prospective randomized controlled trial. Blood Purif. 2023;52(5):455\u201363. https:\/\/doi.org\/10.1159\/000529076.","journal-title":"Blood Purif"},{"issue":"1","key":"3712_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10047-022-01329-0","volume":"26","author":"T Trakarnvanich","year":"2023","unstructured":"Trakarnvanich T, Sirivongrangson P, Trongtrakul K, Srisawat N. The effect of citrate in cardiovascular system and clot circuit in critically ill patients requiring continuous renal replacement therapy. J Artif Organs. 2023;26(1):53\u201364. https:\/\/doi.org\/10.1007\/s10047-022-01329-0.","journal-title":"J Artif Organs"},{"issue":"2","key":"3712_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2215\/cjn.0000000000000351","volume":"19","author":"M Bai","year":"2024","unstructured":"Bai M, Yu Y, Zhao L, Tian X, Zhou M, Jiao J, et al. Regional citrate anticoagulation versus no anticoagulation for CKRT in patients with liver failure with increased bleeding risk. Clin J Am Soc Nephrol. 2024;19(2):151\u201360. https:\/\/doi.org\/10.2215\/cjn.0000000000000351.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3712_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2020;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"3712_CR31","unstructured":"Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.2. The Cochrane Collaboration. 2021. www.training.cochrane.org\/handbook."},{"issue":"11","key":"3712_CR32","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358. https:\/\/doi.org\/10.1002\/sim.1186.","journal-title":"Stat Med"},{"issue":"1","key":"3712_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-020-0648-y","volume":"10","author":"A Karkar","year":"2020","unstructured":"Karkar A, Ronco C. Prescription of CRRT: a pathway to optimize therapy. Ann Intensive Care. 2020;10(1):32. https:\/\/doi.org\/10.1186\/s13613-020-0648-y.","journal-title":"Ann Intensive Care"},{"issue":"6","key":"3712_CR34","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/sdi.12974","volume":"34","author":"JA Neyra","year":"2021","unstructured":"Neyra JA, Tolwani A. CRRT prescription and delivery of dose. Semin Dial. 2021;34(6):432\u20139. https:\/\/doi.org\/10.1111\/sdi.12974.","journal-title":"Semin Dial"},{"issue":"7109","key":"3712_CR35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"4","key":"3712_CR36","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"3712_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/aor.14872","volume":"49","author":"H Im","year":"2025","unstructured":"Im H, Jeong J, Oh SY, Lim L, Lee H, Ryu HG. Impact of renal replacement therapy modality on coagulation and platelet function in critically ill patients: a prospective observational study. Artif Organs. 2025;49(1):21\u201330. https:\/\/doi.org\/10.1111\/aor.14872.","journal-title":"Artif Organs"},{"issue":"1","key":"3712_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-04401-y","volume":"26","author":"E \u00c1vila","year":"2025","unstructured":"\u00c1vila E, Sep\u00falveda RA, Retamal J, Hachim D. Biocompatibility in hemodialysis: artificial membrane and human blood interactions. BMC Nephrol. 2025;26(1):482. https:\/\/doi.org\/10.1186\/s12882-025-04401-y.","journal-title":"BMC Nephrol"},{"issue":"1","key":"3712_CR39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.transci.2016.12.013","volume":"56","author":"M Monchi","year":"2017","unstructured":"Monchi M. Citrate pathophysiology and metabolism. Transfus Apher Sci. 2017;56(1):28\u201330. https:\/\/doi.org\/10.1016\/j.transci.2016.12.013.","journal-title":"Transfus Apher Sci"},{"issue":"6","key":"3712_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2023.151481","volume":"43","author":"T Demuynck","year":"2023","unstructured":"Demuynck T, Grooteman M, Ter Wee P, Cozzolino M, Meijers B. Regional citrate anticoagulation: a tale of more than two stories. Semin Nephrol. 2023;43(6):151481. https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151481.","journal-title":"Semin Nephrol"},{"issue":"1","key":"3712_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaf360","volume":"19","author":"C Liu","year":"2026","unstructured":"Liu C, Fan S, Yang L, Wei W, Huang Y, Chen Z, et al. Higher blood flow rates in anticoagulation-free CRRT improve circuit survival and clinical outcome. Clin Kidney J. 2026;19(1):sfaf360. https:\/\/doi.org\/10.1093\/ckj\/sfaf360.","journal-title":"Clin Kidney J"},{"issue":"8","key":"3712_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0330845","volume":"20","author":"C Liu","year":"2025","unstructured":"Liu C, Bu Q, Wang F, Wei W, Huang Y, Ren J, et al. Effects of different blood flow rates on filter and circuit life in non-anticoagulation CRRT: protocol for a three-arm, single-blind randomized controlled trial (the Flow-CRRT Study). PLoS ONE. 2025;20(8):e0330845. https:\/\/doi.org\/10.1371\/journal.pone.0330845.","journal-title":"PLoS ONE"},{"issue":"3","key":"3712_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2478\/jtim-2018-0026","volume":"6","author":"PM Honore","year":"2018","unstructured":"Honore PM, De Bels D, Preseau T, Redant S, Spapen HD. Citrate: how to get started and what, when, and how to monitor? J Transl Intern Med. 2018;6(3):115\u201327. https:\/\/doi.org\/10.2478\/jtim-2018-0026.","journal-title":"J Transl Intern Med"},{"issue":"1","key":"3712_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05867-8","volume":"12","author":"P Thanapongsatorn","year":"2022","unstructured":"Thanapongsatorn P, Chaijamorn W, Sirivongrangson P, Tachaboon S, Peerapornratana S, Lumlertgul N, et al. Citrate pharmacokinetics in critically ill liver failure patients receiving CRRT. Sci Rep. 2022;12(1):1815. https:\/\/doi.org\/10.1038\/s41598-022-05867-8.","journal-title":"Sci Rep"},{"key":"3712_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1031796","volume":"10","author":"B Peng","year":"2023","unstructured":"Peng B, Lu J, Guo H, Liu J, Li A. Regional citrate anticoagulation for replacement therapy in patients with liver failure: a systematic review and meta-analysis. Front Nutr. 2023;10:1031796. https:\/\/doi.org\/10.3389\/fnut.2023.1031796.","journal-title":"Front Nutr"},{"issue":"1","key":"3712_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-023-01113-0","volume":"13","author":"W Boer","year":"2023","unstructured":"Boer W, Verbrugghe W, Hoste E, Jacobs R, Jorens PG. Unapparent systemic effects of regional anticoagulation with citrate in continuous renal replacement therapy: a narrative review. Ann Intensive Care. 2023;13(1):16. https:\/\/doi.org\/10.1186\/s13613-023-01113-0.","journal-title":"Ann Intensive Care"},{"key":"3712_CR47","doi-asserted-by":"publisher","first-page":"1442065","DOI":"10.3389\/fmed.2024.1442065","volume":"11","author":"C Hu","year":"2024","unstructured":"Hu C, Shui P, Zhang B, Xu X, Wang Z, Wang B, et al. How to safeguard the continuous renal replacement therapy circuit: a narrative review. Front Med (Lausanne). 2024;11:1442065. https:\/\/doi.org\/10.3389\/fmed.2024.1442065.","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"3712_CR48","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.34067\/kid.0000792022","volume":"3","author":"SC Gautam","year":"2022","unstructured":"Gautam SC, Lim J, Jaar BG. Complications associated with continuous RRT. Kidney360. 2022;3(11):1980\u201390. https:\/\/doi.org\/10.34067\/kid.0000792022.","journal-title":"Kidney360"},{"issue":"6","key":"3712_CR49","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1007\/s12325-025-03186-8","volume":"42","author":"C Rognoni","year":"2025","unstructured":"Rognoni C, Pohlmeier R, Tarricone R. Regional citrate anticoagulation versus systemic heparin in continuous kidney replacement therapy: examining the role of evidence in health technology assessment. Adv Ther. 2025;42(6):2606\u201338. https:\/\/doi.org\/10.1007\/s12325-025-03186-8.","journal-title":"Adv Ther"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03712-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03712-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03712-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:40:07Z","timestamp":1790610007000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-026-03712-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3712"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03712-2","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"10 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Wenlong Li, Jun Xie, Chong Huang, Chengyun Xu, and Yan Chen have nothing to disclose.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}